Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer To Present ALLHAT Analysis At Advisory Committee On Antihypertensive Labeling

Jun 14 2005

• By Andrew Kasper

Related Content

FDA Proposes Antihypertensive Class Indication For Reducing CV Events

Jun 13 2005

Pfizer Norvasc Advisory Committee Review Cancelled

Mar 23 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window